Association between ligands and receptors related to the progression of early breast cancer in tumor epithelial and stromal cells

Clinical Breast Cancer

Volumn 15, Issue 1, 2015, Pages e13-e21

  Labovsky, Vivian ^a   Martinez, Leandro Marcelo ^a   Davies, Kevin Mauro ^b   García Rivello, Hernán ^b   De Luján Calcagno, María ^c   Matas, Ayelén ^a   Fernández Vallone, Valeria Beatriz ^a   Wernicke, Alejandra ^b   Choi, Hosoon ^d   Chasseing, Norma Alejandra ^a  

^a National Council of Scientific and Technical Research ^*  (Argentina)

^b HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Breast cancer; Ligands; Receptors; Stromal cells; Tumor epithelial cells

Indexed keywords

ANTIGEN; CD115 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR4; COLONY STIMULATING FACTOR 1; DEATH RECEPTOR; DEATH RECEPTOR 1; DEATH RECEPTOR 2; DEATH RECEPTOR 3; DEATH RECEPTOR 4; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LIGAND; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; CCL2 PROTEIN, HUMAN; CXCL12 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; TNFSF11 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; EARLY CANCER; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; SPINDLE CELL; STROMA CELL; BREAST TUMOR; DISEASE COURSE; FEMALE; METABOLISM; PATHOLOGY;

BREAST NEOPLASMS; CHEMOKINE CCL2; CHEMOKINE CXCL12; DISEASE PROGRESSION; EPITHELIAL CELLS; FEMALE; HUMANS; INTERLEUKIN-6; LIGANDS; RANK LIGAND; RECEPTORS, IMMUNOLOGIC; RECEPTORS, INTERLEUKIN-6; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; STROMAL CELLS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84920496034     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2014.05.006     Document Type: Article

References (42)

1. D.A. Beacham, and E. Cukierman Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression Semin Cancer Biol 15 2005 329 341
2. J. Wels, R.N. Kaplan, and S. Rafii Migratory neighbors and distant invaders: tumor-associated niche cells Genes Dev 22 2008 559 574
3. B.Y. Reddy, P.K. Lim, and K. Silverio The microenvironmental effect in the progression, metastasis, and dormancy of breast cancer: a model system within bone marrow Int J Breast Cancer 2012 2012 721659
4. L.V. Rhodes, J.W. Antoon, and S.E. Muir Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk Mol Cancer 9 2010 295
5. C. Senst, T. Nazari-Shafti, and S. Kruger Prospective dual role of mesenchymal stem cells in breast tumor microenvironment Breast Cancer Res Treat 137 2013 69 79
6. X. Yang, J. Hou, and Z. Han One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment Cell Biosci 3 2013 5
7. C.P. El-Haibi, G.W. Bell, and J. Zhang Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy Proc Natl Acad Sci U S A 109 2012 17460 17465
8. F.T. Martin, R.M. Dwyer, and J. Kelly Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT) Breast Cancer Res Treat 124 2010 317 326
9. Y. Rattigan, J.M. Hsu, and P.J. Mishra Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu Exp Cell Res 316 2010 3417 3424
10. I.A. Ho, and P.Y. Lam Signaling molecules and pathways involved in MSC tumor tropism Histol Histopathol 28 2013 1427 1438
11. K. Räsänen, and A. Vaheri Activation of fibroblasts in cancer stroma Exp Cell Res 316 2010 2713 2722
12. H.F. Zhao, J. Chen, and Z.S. Xu Distribution and differentiation of mesenchymal stem cells in tumor tissue Chin Med J 122 2009 712 715
13. M.E. Hammond, D.F. Hayes, and M. Dowsett American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer J Clin Oncol 28 2010 2784 2795
14. L.M. Martinez, V. Labovsky, and M.L. Calcagno CD105 expression by stromal cells of primary tumours from untreated early breast cancer patients associates with bone metastatic development [abstract] IBMS BoneKEy P083 2013 S54
15. G. Lorusso, and C. Rüegg The tumor microenvironment and its contribution to tumor evolution toward metastasis Histochem Cell Biol 130 2008 1091 1103
16. N. Kovacic, P.I. Croucher, and M.M. McDonald Signaling between tumor cells and the host bone marrow microenvironment Calcif Tissue Int 94 2014 125 139
17. T. Ibrahim, E. Sacanna, and M. Gaudio Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients Clin Breast Cancer 11 2011 369 375
18. S.S. Cross, R.F. Harrison, and S.P. Balasubramanian Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables J Clin Pathol 59 2006 716 720
19. F.C. Kimberley, and G.R. Screaton Following a TRAIL: update on a ligand and its five receptors Cell Res 14 2004 359 372
20. D. Mérino, N. Lalaoui, and A. Morizot Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2 Mol Cell Biol 26 2004 7046 7055
21. S. Owen, L. Ye, and A.J. Sanders Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer Anticancer Res 33 2013 199 206
22. J. Wang, Q. He, and Y.G. Shao Chemokines fluctuate in the progression of primary breast cancer Eur Rev Med Pharmacol Sci 17 2013 596 608
23. N.J. Sullivan Interleukin-6 in the Breast Tumor Microenvironment, Breast Cancer-Focusing Tumor Microenvironment, Stem Cells and Metastasis M. Gunduz, 2011 Ohio State University Columbus, OH 166 182 Available at: http://cdn.intechopen.com/pdfs-wm/24881.pdf
24. D. Schramek, V. Sigl, and J.M. Penninger RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis Trends Endocrinol Metab 22 2011 188 194
25. A.D. Papanstasiau, C. Sirinian, and H.P. Kalofonos Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration Breast Cancer Res 14 2012 R112
26. D. Malin, F. Chen, and C. Schiller Enhanced metastasis suppression by targeting TRAIL receptor 2 in a murine model of triple-negative breast cancer Clin Cancer Res 17 2011 5005 5015
27. P. Sansone, G. Storci, and S. Tavolari IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland J Clin Invest 117 2007 3988 4002
28. Y. Kojima, A. Acar, and E.N. Eaton Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts Proc Natl Acad Sci U S A 107 2010 20009 20014
29. S. Ławicki, M. Czygier, and E. Bedkowska Comparative evaluation of plasma levels and diagnostic values of macrophage-colony stimulating factor in patients with breast cancer and benign tumors Pol Arch Med Wewn 118 2008 464 469
30. W.B. Fang, I. Jokar, and A. Zou CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms J Biol Chem 287 2012 36593 36608
31. A. Morandi, V. Barbetti, and M. Riverso The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines PLoS One 6 2011 e27450
32. X. Liu, B. Duan, and Z. Cheng SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion Protein Cell 2 2011 845 854
33. J. Dittmer, I. Oerlecke, and B. Leyh Involvement of Mesenchymal Stem Cells in Breast Cancer Progression, Breast Cancer - Focusing Tumor Microenvironment, Stem Cells and Metastasis Chapter 12 M. Gunduz, 2011 Ohio State University The Ohio State University, Columbus, OH 247 272 Available at: http://www.researchgate.net/publication/221921077-Involvement-of-Mesenchymal-Stem-Cells-in-Breast-Cancer-Progression
34. R.M. Dwyer, S.M. Potter-Beirne, and K.A. Harrington Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells Clin Cancer Res 13 2007 5020 5027
35. K. Tawara, J.T. Oxford, and C.L. Jorcyk Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies Cancer Manag Res 3 2011 177 189
36. A.L. Ponte, E. Marais, and N. Gallay The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities Stem Cells 25 2007 1737 1745
37. T. Marsh, K. Pietras, and S.S. McAllister Fibroblasts as architects of cancer pathogenesis Biochim Biophys Acta 1832 2013 1070 1078
38. S.M. Kim, D.S. Kim, and C.H. Jeong CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas Biochem Biophys Res Commun 407 2011 741 746
39. S. Liu, C. Ginestier, and S.J. Ou Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks Cancer Res 71 2011 614 624
40. M. Mimeault, and S.K. Batra Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies Mol Aspects Med August 29, 2013 [Epub ahead of print]
41. M. Palafox, I. Ferrer, and P. Pellegrini RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis Cancer Res 72 2012 2879 2888
42. S.M. Potter, R.M. Dwyer, and M.C. Hartmann Influence of stromal-epithelial interactions on breast cancer in vitro and in vivo Breast Cancer Res Treat 131 2012 401 411